These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7587103)

  • 1. p16INK4 mutations and altered expression in human tumors and cell lines.
    Okamoto A; Demetrick DJ; Spillare EA; Hagiwara K; Hussain SP; Bennett WP; Forrester K; Gerwin B; Greenblatt MS; Serrano M
    Cold Spring Harb Symp Quant Biol; 1994; 59():49-57. PubMed ID: 7587103
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations and altered expression of p16INK4 in human cancer.
    Okamoto A; Demetrick DJ; Spillare EA; Hagiwara K; Hussain SP; Bennett WP; Forrester K; Gerwin B; Serrano M; Beach DH
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11045-9. PubMed ID: 7972006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the cyclin-dependent kinase inhibitors p16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer.
    Musgrove EA; Lilischkis R; Cornish AL; Lee CS; Setlur V; Seshadri R; Sutherland RL
    Int J Cancer; 1995 Nov; 63(4):584-91. PubMed ID: 7591270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
    Lukas J; Aagaard L; Strauss M; Bartek J
    Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
    Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
    Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
    Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
    Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion and differential expression of p16INK4a in mouse lung tumors.
    Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
    Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2.
    Peters G; Parry D; Hara E; Hall M; Bates S; Palmero I
    Leukemia; 1997 Apr; 11 Suppl 3():352-5. PubMed ID: 9209387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.
    Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC
    Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.
    Igaki H; Sasaki H; Kishi T; Sakamoto H; Tachimori Y; Kato H; Watanabe H; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1090-5. PubMed ID: 8093026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
    Maelandsmo GM; Berner JM; Flørenes VA; Forus A; Hovig E; Fodstad O; Myklebost O
    Br J Cancer; 1995 Aug; 72(2):393-8. PubMed ID: 7640224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in molecular mechanisms of leukemogenesis: the cyclin-dependent kinase 4-inhibitor gene in human leukemias.
    Hirai H; Ogawa S; Hangaishi A; Takahashi T; Kurokawa M; Mitani K; Ueda R; Yazaki Y
    Leukemia; 1997 Apr; 11 Suppl 3():358-60. PubMed ID: 9209389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas.
    Tenan M; Benedetti S; Finocchiaro G
    Biochem Biophys Res Commun; 1995 Dec; 217(1):195-202. PubMed ID: 8526910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppression by p16ink4 requires functional retinoblastoma protein.
    Medema RH; Herrera RE; Lam F; Weinberg RA
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6289-93. PubMed ID: 7603984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K; Hussussian CJ; Sikorski RS; Varmus HE; Goldstein AM; Tucker MA; Serrano M; Hannon GJ; Beach D; Dracopoli NC
    Nat Genet; 1995 May; 10(1):114-6. PubMed ID: 7647780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.